Cancer Advances Rely on U.S. Funding: Report

WEDNESDAY, Sept. 12, 2018 — Almost two dozen new cancer treatments received U.S. Food and Drug Administration approval in the past year, a new report reveals.
These treatments include innovative immunotherapies that target cancer cells (called CAR…
Source: Topamax